SIBN icon

SI-BONE Inc

15.70 USD
-0.62
3.8%
At close Updated Sep 12, 4:00 PM EDT
Pre-market
After hours
15.70
0.00
0%
1 day
-3.8%
5 days
-3.92%
1 month
3.29%
3 months
-14.02%
6 months
6.44%
Year to date
12.71%
1 year
2.21%
5 years
-32.06%
10 years
-21.73%
 

About: SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Employees: 349

0
Funds holding %
of 7,462 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

6,908% more call options, than puts

Call options by funds: $1.68M | Put options by funds: $24K

118% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 17

35% more capital invested

Capital invested by funds: $567M [Q1] → $769M (+$201M) [Q2]

12% more funds holding

Funds holding: 158 [Q1] → 177 (+19) [Q2]

5% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 56

0.57% more ownership

Funds ownership: 95.28% [Q1] → 95.85% (+0.57%) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$25
59% upside
Avg. target
$25
59% upside
High target
$25
59% upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Cantor Fitzgerald
Ross Osborn
$25
Overweight
Reiterated
5 Aug 2025

Financial journalist opinion

Neutral
Seeking Alpha
5 days ago
SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
SI-BONE, Inc. (NASDAQ:SIBN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:00 AM EDT Company Participants Laura Francis - CEO & Director Anshul Maheshwari - Chief Financial Officer Presentation Unknown Analyst All right. Good morning.
SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Neutral
GlobeNewsWire
19 days ago
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025
SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Tuesday, September 9, 2025, at 4:00 a.m. Pacific Time/ 07:00 a.m. Eastern Time.
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025
Positive
The Motley Fool
1 month ago
Si-bone (SIBN) Q2 Revenue Jumps 22%
Si-bone (SIBN 2.93%), a medical device innovator focused on minimally invasive surgery for joint dysfunction and pelvic conditions, released its second quarter 2025 results on August 4, 2025. The company reported GAAP revenue of $48.6 million and a GAAP net loss per share of $(0.14) for Q2 2025.
Si-bone (SIBN) Q2 Revenue Jumps 22%
Neutral
Seeking Alpha
1 month ago
SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript
SI-BONE, Inc. (NASDAQ:SIBN ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Anshul Maheshwari - Chief Financial Officer Laura A. Francis - CEO & Director Saqib Iqbal - Director of FP&A and Investor Relations Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Craig William Bijou - BofA Securities, Research Division David Joshua Saxon - Needham & Company, LLC, Research Division David Louis Turkaly - Citizens JMP Securities, LLC, Research Division Felipe Raul Lamar - Truist Securities, Inc., Research Division Junwoo Park - Cantor Fitzgerald & Co., Research Division Matthew Oliver O'Brien - Piper Sandler & Co., Research Division Xuyang Li - Jefferies LLC, Research Division Operator Good afternoon, and welcome to SI-BONE Second Quarter 2025 Earnings Conference Call.
SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.22 per share a year ago.
Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance
Achieved ~22% worldwide revenue growth, positive Adjusted EBITDA and cash flow breakeven Achieved ~22% worldwide revenue growth, positive Adjusted EBITDA and cash flow breakeven
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance
Neutral
GlobeNewsWire
1 month ago
SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025
SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, August 12, 2025, at 12:00 p.m. Pacific Time/03:00 p.m. Eastern Time.
SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025
Neutral
GlobeNewsWire
2 months ago
SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second quarter of 2025 after market close on Monday, August 4, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
Positive
Zacks Investment Research
2 months ago
All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy
Si-Bone (SIBN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy
Neutral
GlobeNewsWire
3 months ago
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, June 17, 2025, at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time.
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
Charts implemented using Lightweight Charts™